(−)-Englerin A-evoked Cytotoxicity Is Mediated by Na+ Influx and Counteracted by Na+/K+-ATPase*

(−)-Englerin A ((−)-EA) has a rapid and potent cytotoxic effect on several types of cancer cell that is mediated by plasma membrane ion channels containing transient receptor potential canonical 4 (TRPC4) protein. Because these channels are Ca2+-permeable, it was initially thought that the cytotoxicity arose as a consequence of Ca2+ overload. Here we show that this is not the case and that the effect of (−)-EA is mediated by a heteromer of TRPC4 and TRPC1 proteins. Both TRPC4 and TRPC1 were required for (−)-EA cytotoxicity; however, although TRPC4 was necessary for the (−)-EA-evoked Ca2+ elevation, TRPC1 was not. TRPC1 either had no role or was a negative regulator of Ca2+ entry. By contrast, both TRPC4 and TRPC1 were necessary for monovalent cation entry evoked by (−)-EA, and (−)-EA-evoked cell death was dependent upon entry of the monovalent cation Na+. We therefore hypothesized that Na+/K+-ATPase might act protectively by counteracting the Na+ load resulting from sustained Na+ entry. Indeed, inhibition of Na+/K+-ATPase by ouabain potently and strongly increased (−)-EA-evoked cytotoxicity. The data suggest that (−)-EA achieves cancer cell cytotoxicity by inducing sustained Na+ entry through heteromeric TRPC1/TRPC4 channels and that the cytotoxic effect of (−)-EA can be potentiated by Na+/K+-ATPase inhibition.

[1]  William J. Chain,et al.  A brief synthesis of (-)-englerin A. , 2011, Journal of the American Chemical Society.

[2]  K. Gustafson,et al.  Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri. , 2009, Organic letters.

[3]  L. Neckers,et al.  Synthesis of a stable and orally bioavailable englerin analogue. , 2016, Bioorganic & medicinal chemistry letters.

[4]  David Attwell,et al.  Non-signalling energy use in the brain , 2015, The Journal of physiology.

[5]  Herbert Waldmann,et al.  (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels. , 2015, Angewandte Chemie.

[6]  W. Linehan,et al.  Englerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethality. , 2013, Cancer cell.

[7]  D. Clapham,et al.  TRPC1 and TRPC5 Form a Novel Cation Channel in Mammalian Brain , 2001, Neuron.

[8]  K. Kohn,et al.  CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set. , 2012, Cancer research.

[9]  B. Christensen,et al.  Epigenetic silencing of Na,K-ATPase β1 subunit gene ATP1B1 by methylation in clear cell renal cell carcinoma , 2014, Epigenetics.

[10]  L. Vaca,et al.  Regulation of the cellular localization and function of human transient receptor potential channel 1 by other members of the TRPC family. , 2008, Cell calcium.

[11]  T. Gudermann,et al.  Transient Receptor Potential Channel 1 (TRPC1) Reduces Calcium Permeability in Heteromeric Channel Complexes , 2011, The Journal of Biological Chemistry.

[12]  T. Gudermann,et al.  Receptor-mediated Regulation of the Nonselective Cation Channels TRPC4 and TRPC5* , 2000, The Journal of Biological Chemistry.

[13]  Nathan T. Ross,et al.  Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation , 2015, PloS one.

[14]  N. Bander,et al.  Reduced expression of beta-subunit of Na,K-ATPase in human clear-cell renal cell carcinoma. , 1999, The Journal of urology.

[15]  C. Stournaras,et al.  Na+/K+ ATPase inhibitors in cancer. , 2014, Current drug targets.

[16]  Jing Li,et al.  Natural and synthetic flavonoid modulation of TRPC5 channels , 2016, British journal of pharmacology.

[17]  R. Fröhlich,et al.  Total synthesis and biological evaluation of (-)-englerin A and B: synthesis of analogues with improved activity profile. , 2011, Angewandte Chemie.

[18]  T. Gudermann,et al.  Classical Transient Receptor Potential 1 (TRPC1): Channel or Channel Regulator? , 2014, Cells.

[19]  M. Schaefer,et al.  TRPC4 and TRPC5: receptor-operated Ca2+-permeable nonselective cation channels. , 2003, Cell calcium.

[20]  J. Beutler,et al.  Synthesis and Biological Evaluation of New (−)‐Englerin Analogues , 2016, ChemMedChem.

[21]  A. Cheong,et al.  A Sphingosine-1–Phosphate–Activated Calcium Channel Controlling Vascular Smooth Muscle Cell Motility , 2006, Circulation research.

[22]  L. Birnbaumer,et al.  TRPC1 proteins confer PKC and phosphoinositol activation on native heteromeric TRPC1/C5 channels in vascular smooth muscle: comparative study of wild‐type and TRPC1−/− mice , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  I. So,et al.  Isoform- and receptor-specific channel property of canonical transient receptor potential (TRPC)1/4 channels , 2014, Pflügers Archiv: European Journal of Physiology.

[24]  William C Reinhold,et al.  CellMiner: a relational database and query tool for the NCI-60 cancer cell lines , 2009, BMC Genomics.